The RAND study revealed confusion among veterans about the VA's policies regarding psychedelics.
The increased acceptance and research into psychedelics for therapeutic uses, combined with ongoing veteran mental health crises, make this an opportune time for such a study.
This data point highlights a significant, unaddressed trend in veteran self-medication and points to a potential shift in official medical and veteran support policies.
The revealed widespread use and policy confusion will put pressure on the VA and other governmental bodies to clarify and potentially liberalize their stance on psychedelic therapies for veterans.
- · Veterans seeking alternative therapies
- · Psychedelic research institutions
- · Mental health advocacy groups
- · Traditional pharmaceutical companies (in this specific niche)
- · Bureaucracies slow to adapt policy
The VA will face increased public and internal pressure to develop clear policies regarding psychedelics.
Expanded access to psychedelic therapies for veterans could lead to a broader liberalization of drug policies across the medical landscape.
Successful integration of psychedelics into veteran healthcare could significantly reduce rates of PTSD and depression among former service members, impacting broader societal well-being and workforce participation.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at Army Times